WIN 2018 Presentations

WIN Symposium 2018 presentations

To view presentations in PDF format, click on the lecture title. Note that not all speakers have given their consent for release of their presentation.

Monday June 25, 2018

PRESIDENTIAL SESSION 1: The challenges of building real cooperation to implement Precision Oncology programs: A long and winding road

Keynote Lecture: The TAPUR family of clinical trials: building a global data sharing platform in Precision Oncology
Richard L. Schilsky, American Society of Clinical Oncology (ASCO), USA
View Presentation

U.S. National Cancer Institute perspective on Precision Oncology
James H. Doroshow, National Cancer Institute (NCI), USA
View Presentation

SESSION 2: The next frontier of therapeutics in newly diagnosed patients: standard of care or modern biomarker driven Precision Cncology?

A new world of early diagnosis to defeat Non-Small Cell Lung Carcinoma (NSCLC); The WIN Consortium BOOSTER trial for identification and validation of new blood biomarkers for NSCLC
Amir Onn, Sheba Medical Center, Israel
View Presentation

Lessons from long-term survey of Stage I NSCLC
Harvey I. Pass, New York University (NYU), Langone Health, USA
View Presentation

Keynote Lecture: Patients driving progress
Ellen V. Sigal, Friends of Cancer Research, USA
View Presentation

Tuesday June 26, 2018

SESSION 3: Disruptive concepts and clinical trials shifting the paradigm of Precision Oncology

MyPathway study: a novel precision oncology multiple basket trial
Mary Beattie, Genentech, USA
View Presentation

SESSION 4: New concepts and therapeutics avenues in Precision Oncology

Keynote Lecture: Precision CAR T-cells therapeutics
Carl H. June, Perelman School of Medicine, 2017 David A. Karnofsky Memorial Award ASCO, USA
View Presentation

Precision Oncology approaches for immunotherapy
Eric Rubin, Merck Sharp & Dohme, USA
View Presentation

Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?
Giorgio Massimini, Merck KGaA, Germany
View Presentation

SESSION 5: Using new knowledge in clinical trials

Implementing Precision Medicine in Oncology: The IMPACT Clinical Trials at MD Anderson
Apostolia-Maria Tsimberidou, University of Texas, MD Anderson Cancer Center (UT-MDACC), USA
View Presentation

The ‘greatest hits’ of Precision Oncology: the view from the newsroom
Bernadette Toner, GenomeWeb, USA
View Presentation

Patients’ access to Precision Oncology
Francesco De Lorenzo, European Cancer Patient Coalition (ECPC), Belgium
View Presentation

SESSION 6: Best Poster Presentations

Dynamic monitoring HER2 amplification of circulating DNA in metastatic colorectal cancer patients treated
with cetuximab
Rujiao Liu, Shanghai Cancer Center, Shanghai, People’s Republic of China
View Presentation